These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 12474535)
1. The clinical role of prostate-specific membrane antigen (PSMA). Chang SS; Heston WD Urol Oncol; 2002; 7(1):7-12. PubMed ID: 12474535 [TBL] [Abstract][Full Text] [Related]
2. Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature. Chang SS; Reuter VE; Heston WD; Bander NH; Grauer LS; Gaudin PB Cancer Res; 1999 Jul; 59(13):3192-8. PubMed ID: 10397265 [TBL] [Abstract][Full Text] [Related]
3. Measurement of serum prostate-specific membrane antigen, a new prognostic marker for prostate cancer. Murphy GP; Kenny GM; Ragde H; Wolfert RL; Boynton AL; Holmes EH; Misrock SL; Bartsch G; Klocker H; Pointner J; Reissigl A; McLeod DG; Douglas T; Morgan T; Gilbaugh J Urology; 1998 May; 51(5A Suppl):89-97. PubMed ID: 9610563 [TBL] [Abstract][Full Text] [Related]
4. Comparison of anti-prostate-specific membrane antigen antibodies and other immunomarkers in metastatic prostate carcinoma. Chang SS; Reuter VE; Heston WD; Gaudin PB Urology; 2001 Jun; 57(6):1179-83. PubMed ID: 11377343 [TBL] [Abstract][Full Text] [Related]
5. In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen. Smith-Jones PM; Vallabahajosula S; Goldsmith SJ; Navarro V; Hunter CJ; Bastidas D; Bander NH Cancer Res; 2000 Sep; 60(18):5237-43. PubMed ID: 11016653 [TBL] [Abstract][Full Text] [Related]
6. Prostate-specific membrane antigen: current and future utility. Gregorakis AK; Holmes EH; Murphy GP Semin Urol Oncol; 1998 Feb; 16(1):2-12. PubMed ID: 9508077 [TBL] [Abstract][Full Text] [Related]
7. Current evaluation of the tissue localization and diagnostic utility of prostate specific membrane antigen. Murphy GP; Elgamal AA; Su SL; Bostwick DG; Holmes EH Cancer; 1998 Dec; 83(11):2259-69. PubMed ID: 9840525 [TBL] [Abstract][Full Text] [Related]
8. Short term neoadjuvant androgen deprivation therapy does not affect prostate specific membrane antigen expression in prostate tissues. Chang SS; Reuter VE; Heston WD; Hutchinson B; Grauer LS; Gaudin PB Cancer; 2000 Jan; 88(2):407-15. PubMed ID: 10640975 [TBL] [Abstract][Full Text] [Related]
9. Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor. Smith-Jones PM; Vallabhajosula S; Navarro V; Bastidas D; Goldsmith SJ; Bander NH J Nucl Med; 2003 Apr; 44(4):610-7. PubMed ID: 12679407 [TBL] [Abstract][Full Text] [Related]
10. Prostate-specific membrane antigen (PSMA)-specific monoclonal antibodies in the treatment of prostate and other cancers. Gong MC; Chang SS; Sadelain M; Bander NH; Heston WD Cancer Metastasis Rev; 1999; 18(4):483-90. PubMed ID: 10855791 [TBL] [Abstract][Full Text] [Related]
12. Prostate-Specific Membrane Antigen: Much More Than a Prostate Cancer Marker. Chang SS; Gaudin PB; Reuter VE; O'Keefe DS; Bacich DJ; Heston WD Mol Urol; 1999; 3(3):313-320. PubMed ID: 10851338 [TBL] [Abstract][Full Text] [Related]
13. Quantitation of serum prostate-specific membrane antigen by a novel protein biochip immunoassay discriminates benign from malignant prostate disease. Xiao Z; Adam BL; Cazares LH; Clements MA; Davis JW; Schellhammer PF; Dalmasso EA; Wright GL Cancer Res; 2001 Aug; 61(16):6029-33. PubMed ID: 11507047 [TBL] [Abstract][Full Text] [Related]
14. Prostate-specific membrane antigen levels in sera from healthy men and patients with benign prostate hyperplasia or prostate cancer. Beckett ML; Cazares LH; Vlahou A; Schellhammer PF; Wright GL Clin Cancer Res; 1999 Dec; 5(12):4034-40. PubMed ID: 10632336 [TBL] [Abstract][Full Text] [Related]
15. The utility of monoclonal antibodies in the imaging of prostate cancer. Yao D; Trabulsi EJ; Kostakoglu L; Vallabhajosula S; Joyce MA; Nanus DM; Milowsky M; Liu H; Goldsmith SJ Semin Urol Oncol; 2002 Aug; 20(3):211-8. PubMed ID: 12215974 [TBL] [Abstract][Full Text] [Related]
16. Prostate-specific membrane antigen (PSMA): current benefits and future value. Elgamal AA; Holmes EH; Su SL; Tino WT; Simmons SJ; Peterson M; Greene TG; Boynton AL; Murphy GP Semin Surg Oncol; 2000; 18(1):10-6. PubMed ID: 10617892 [TBL] [Abstract][Full Text] [Related]
17. Prostate-specific membrane antigen expression in normal and malignant human tissues. Silver DA; Pellicer I; Fair WR; Heston WD; Cordon-Cardo C Clin Cancer Res; 1997 Jan; 3(1):81-5. PubMed ID: 9815541 [TBL] [Abstract][Full Text] [Related]
18. A new generation of monoclonal and recombinant antibodies against cell-adherent prostate specific membrane antigen for diagnostic and therapeutic targeting of prostate cancer. Elsässer-Beile U; Wolf P; Gierschner D; Bühler P; Schultze-Seemann W; Wetterauer U Prostate; 2006 Sep; 66(13):1359-70. PubMed ID: 16894535 [TBL] [Abstract][Full Text] [Related]